News Coverage 11.07.19 By: Arlene Weintraub Share on Twitter Share on Facebook Share on LinkedIn ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study Related Announcement PICI 2024: Collaborative Breakthroughs in Cancer Immunotherapy Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research